TACS•XL® DAB Kit is designed for use with fixed frozen or paraffin embedded tissue sections. All the reagents required for the labeling and detection of fragmented DNA and to assist in the identification of apoptotic morphologies are provided including two permeabilization reagents, labeling and detection reagents, stop buffers, DAB and Methyl Green counterstain as well as TACS-Nuclease™ for generating positive controls with your own samples.
Please refer to our components listing for details.
Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma
Shao, R., Francescone, R., Ngernyuang, N., Bentley, B., Taylor, S.L., Moral, L., and Yan, W., Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma41671CarcinogenesisCarcinogenesis373
Carcinogenesis, Feb 2014; 35: 373 – 382
Hepatic Serum Amyloid A1 Aggravates T Cell-mediated Hepatitis by Inducing Chemokines via Toll-like Receptor 2 in Mice
“Young Rae Ji, Hei Jung Kim, Ki Beom Bae, Sanggyu Lee, Myoung Ok Kim, and Zae Young Ryoo”
J. Biol. Chem., May 2015; 290: 12804 – 12811.
Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma
Heather Francois-Vaughan, Adeola O. Adebayo, Kate E. Brilliant, Nicola M.A. Parry, Philip A. Gruppuso, and Jennifer A. Sanders
Carcinogenesis, Apr 2016; 37: 408 – 419.
“Mechanistic Target of Rapamycin (mTOR) Inhibition Synergizes with
Reduced Internal Ribosome Entry Site (IRES)-mediated Translation of
Cyclin D1 and c-MYC mRNAs to Treat Glioblastoma”
“Brent Holmes, Jihye Lee, Kenna A. Landon, Angelica Benavides-Serrato, Tariq Bashir, Michael E. Jung, Alan Lichtenstein, and Joseph Gera”
J. Biol. Chem., Jul 2016; 291: 14146 – 14159.